Cardiovascular disease

View All

Cardiovascular Disease
Cardiovascular Disease: A major cause of health loss and a global burden

Cardiovascular diseases (CVDs) are one of the leading causes of death and health loss in people in the US. As per a study by the National Vital Statistics Report, every 37 seconds, one person dies of Cardiovascular diseases in the US.  Cardiovascular diseases also known as heart disease, encompasses a wide range...

Find More

Digital therapeutics
Potential of Digital therapeutics and increasing CVDs

The 21st century has been a remarkable century for humankind, as a lot of innovation, research and development has taken place in the field of healthcare, due to which we have been able to increase the overall lifespan of the human beings.  However, the central question is, are we able to increase the healt...

Find More

polypills
Polypills: Can they offer a potential approach to treat CVDs?

Cardiovascular disease (CVD), such as heart attack and stroke, is a leading cause of deaths and hampering the quality of life in the US. Moreover, the disease will continue to afflict the lives of the people by 2020.  High blood pressure, hypertension and high cholesterol are the major comorbidities of CVD,...

Find More

Women Healthcare
Where Women Healthcare Stands

Technology has made an impact on every field. And Healthcare is no exception. Advances in medical technology have proven to be a game-changer in the health sector. But is the case same when Women healthcare comes to mind? It will not be less than a shock to learn that Women were not included in medical research and...

Find More


Delveinsight
Global atrial fibrillation market is expected to grow to $12.5 billion by 2020

Global AF market was $7.2 billion in 2015 and expected to grow to $12.5 billion by 2020 with and compound annual growth rate (CAGR) of 11.62%. There are four NOACs which are indicated for the treatment of AF such as Xarelto, Eliquis, Pradaxa and Savaysa. DelveInsight Atrial Fibrillation-Market Insights & Drugs ...

Find More

Delveinsight
DelveInsight launches Indication Active Pharmaceutical Ingredient (API) Reports

DelveInsight expertise over 400+ Indication Active Pharmaceutical Ingredient (API) Reports DelveInsight, leading Market Research and Business Consulting firm has an expertise in providing business solutions to Pharma and biotech companies. DelveInsight has 400+ Indication API reports on wide range of therapeutic ...

Find More

Delveinsight
DelveInsight’s Gene Therapy Reports: Launched

Immense Growth Potential in the Gene Therapy Market! DelveInsight has launched its Gene Therapy Report: “Gene Therapy Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape”. These Reports are the outcome of very best analytical abilities and diligent market research amalgamated with opin...

Find More

Delveinsight
Gene Therapy’s Emergence: The “New” approach for Huntington’s disease

Many companies have tried over the years to find a way to reverse the course of crippling neurodegenerative disorders like Huntington’s but have failed. Fortunately, Gene therapy has proven to be an answer to a wide range of serious neurodegenerative disorders like Huntington’s, and Parkinson’s etc. The HD gene vs...

Find More

Delveinsight
Break the Gene Therapy Barrier with DelveInsight’s Gene Therapy Reports

Gene Therapy: The Future is here! Scientific research and clinical trials aren’t glamorous, but they are essential for effective treatments and perhaps ultimately a cure for various debilitating diseases like cancer etc. Gene therapy's potential to revolutionize medicine in the future is exciting, and one day it m...

Find More